MicroRNAs as prognostic biomarkers for survival outcome in osteosarcoma: A meta-analysis

No abstract is available for this paper.

• Publication year

  2021

• Venue

  World Journal of Meta-Analysis

• Publication date

  2021-12-28

• Fields of study

  Not labeled

• Identifiers
  DOI 10.13105/wjma.v9.i6.568
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Downregulation of miR-1826 Indicates a Poor Prognosis for Osteosarcoma Patients and Regulates Tumor Cell Proliferation, Migration, and Invasion

  2020cited by this paper
• Identification of plasma microRNA-22 as a marker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma

  2020cited by this paper
• Potential diagnostic value of miRNAs in peripheral blood for osteosarcoma: A meta-analysis

  2020cited by this paper
• Downregulation of serum miR-194 predicts poor prognosis in osteosarcoma patients.

  2020cited by this paper
• MicroRNA-106b serves as a prognostic biomarker and is associated with cell proliferation, migration, and invasion in osteosarcoma.

  2019cited by this paper
• Prognostic significance of circulating microRNA-214 and -126 in dogs with appendicular osteosarcoma receiving amputation and chemotherapy

  2019cited by this paper
• MicroRNA‐1270 is associated with poor prognosis and its inhibition yielded anticancer mechanisms in human osteosarcoma

  2018cited by this paper
• miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting αB-crystallin.

  2017cited by this paper
• MicroRNAs with prognostic significance in osteosarcoma: a systemic review and meta-analysis

  2017cited by this paper
• Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma

  2017cited by this paper
• Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma.

  2017cited by this paper
• Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics

  2017cited by this paper
• Prognostic value of microRNAs in osteosarcoma: a meta-analysis

  2017cited by this paper
• MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma

  2017cited by this paper
• MicroRNA-21 promotes proliferation, invasion and suppresses apoptosis in human osteosarcoma line MG63 through PTEN/Akt pathway

  2016cited by this paper
• Serum miR-300 as a diagnostic and prognostic biomarker in osteosarcoma

  2016cited by this paper
• MicroRNA-21 regulates the sensitivity to cisplatin in a human osteosarcoma cell line

  2016cited by this paper
• Osteosarcoma.

  2016cited by this paper
• Association of circulating miR-125b and survival in patients with osteosarcoma–A single center experience

  2016cited by this paper
• MiR-29b suppresses the proliferation and migration of osteosarcoma cells by targeting CDK6

  2016cited by this paper
• miRNA-223 is a potential diagnostic and prognostic marker for osteosarcoma

  2016cited by this paper
• Chondroblastic osteosarcoma: Cytomorphologic characteristics and differential diagnosis on FNA

  2016cited by this paper
• MiR-326 is a diagnostic biomarker and regulates cell survival and apoptosis by targeting Bcl-2 in osteosarcoma.

  2016cited by this paper
• Update on Survival in Osteosarcoma.

  2016cited by this paper
• miR-21 predicts poor prognosis in patients with osteosarcoma

  2016cited by this paper
• Serum miR-95-3p is a diagnostic and prognostic marker for osteosarcoma

  2016cited by this paper
• Diagnostic and prognostic potentials of microRNA-27a in osteosarcoma.

  2015cited by this paper
• The microRNA-217 functions as a tumor suppressor and is frequently downregulated in human osteosarcoma.

  2015cited by this paper
• Tissue microRNA-126 expression level predicts outcome in human osteosarcoma

  2015cited by this paper
• Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies.

  2015cited by this paper
• Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.

  2015cited by this paper
• Serum miR-195 is a diagnostic and prognostic marker for osteosarcoma.

  2015cited by this paper
• Combined MicroRNA-340 and ROCK1 mRNA Profiling Predicts Tumor Progression and Prognosis in Pediatric Osteosarcoma

  2014cited by this paper
• Serum miR-9 as a prognostic biomarker in patients with osteosarcoma

  2014cited by this paper
• Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.

  2014cited by this paper
• Upregulated expression of microRNA‐214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma

  2014cited by this paper
• Circulating miR-148a is a significant diagnostic and prognostic biomarker for patients with osteosarcoma

  2014cited by this paper
• MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma

  2014cited by this paper
• Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients.

  2014cited by this paper
• Combined Elevation of microRNA-196a and microRNA-196b in Sera Predicts Unfavorable Prognosis in Patients with Osteosarcomas

  2014cited by this paper
• MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1.

  2013cited by this paper
• Loss of microRNA-132 predicts poor prognosis in patients with primary osteosarcoma

  2013cited by this paper
• The long and short of microRNA.

  2013cited by this paper
• Prognostic evaluation of microRNA-210 expression in pediatric osteosarcoma

  2013cited by this paper
• Identification of Serum MicroRNA-21 as a Biomarker for Chemosensitivity and Prognosis in Human Osteosarcoma

  2012cited by this paper
• MicroRNA-21 is involved in osteosarcoma cell invasion and migration

  2011cited by this paper
• Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

  2010cited by this paper
• MicroRNA: Biogenesis, Function and Role in Cancer

  2010cited by this paper
• Practical methods for incorporating summary time-to-event data into meta-analysis

  2007cited by this paper
• Consensus Statement

  2004cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• T E C H N I C a L a D V a N C E Open Access

  year unknowncited by this paper

• No citing papers are available for this paper.